Literature DB >> 10677327

Age estimate of the N370S mutation causing Gaucher disease in Ashkenazi Jews and European populations: A reappraisal of haplotype data.

R Colombo1.   

Abstract

The N370S mutation at the GBA locus on human chromosome 1q21, which causes Gaucher disease (GD), has a high frequency in the Ashkenazim and is the second-most-widespread GD mutation in the European non-Jewish population. A common ancient origin for the N370S mutation in the Ashkenazi Jewish and Spanish populations has been proposed on the basis of both a similar haplotype for associated markers and an age estimate that suggests that this mutation appeared several thousand years ago. However, a reappraisal of haplotype data, using the Risch formula properly along with a Luria-Delbrück setting of the genetic clock, allows identification of the likely origin of the N370S mutation in Ashkenazi Jews between the 11th and 13th centuries. This result is consistent with the estimated ages of other mutations that are frequent among Ashkenazim, with the exception of type II (Glu117Stop) factor XI deficiency, which is deemed to be >3000 years old, predating the separation of the Ashkenazi and Iraqi Jews. The present finding supports the hypothesis of a more recent origin for the N370S mutation and is consistent with both a founder chromosome transfer from Ashkenazim who assimilated in some European populations and a non-Jewish origin of the European N370S-bearing chromosomes.

Entities:  

Mesh:

Year:  2000        PMID: 10677327      PMCID: PMC1288120          DOI: 10.1086/302757

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  22 in total

1.  Gaucher disease: the N370S mutation in Ashkenazi Jewish and Spanish patients has a common origin and arose several thousand years ago.

Authors:  A Díaz; M Montfort; B Cormand; B Zeng; G M Pastores; A Chabás; L Vilageliu; D Grinberg
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

2.  Age estimates of two common mutations causing factor XI deficiency: recent genetic drift is not necessary for elevated disease incidence among Ashkenazi Jews.

Authors:  D B Goldstein; D E Reich; N Bradman; S Usher; U Seligsohn; H Peretz
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

3.  Genetic fine localization of the beta-glucocerebrosidase (GBA) and prosaposin (PSAP) genes: implications for Gaucher disease.

Authors:  B Cormand; M Montfort; A Chabás; L Vilageliu; D Grinberg
Journal:  Hum Genet       Date:  1997-07       Impact factor: 4.132

4.  Estimating the age of mutant disease alleles based on linkage disequilibrium.

Authors:  S W Guo; M Xiong
Journal:  Hum Hered       Date:  1997 Nov-Dec       Impact factor: 0.444

5.  Type 1 Gaucher disease: identification of N396T and prevalence of glucocerebrosidase mutations in the Portuguese.

Authors:  O Amaral; E Pinto; M Fortuna; L Lacerda; M C Sá Miranda
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

6.  Age and origin of two common MLH1 mutations predisposing to hereditary colon cancer.

Authors:  A L Moisio; P Sistonen; J Weissenbach; A de la Chapelle; P Peltomäki
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

7.  Precise genetic mapping and haplotype analysis of the familial dysautonomia gene on human chromosome 9q31.

Authors:  A Blumenfeld; S A Slaugenhaupt; C B Liebert; V Temper; C Maayan; S Gill; D E Lucente; M Idelson; K MacCormack; M A Monahan; J Mull; M Leyne; M Mendillo; T Schiripo; E Mishori; X Breakefield; F B Axelrod; J F Gusella
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

8.  Trinucleotide repeat polymorphism at the PKLR locus.

Authors:  C Lenzner; G Jacobasch; A Reis; B Thiele; P Nürnberg
Journal:  Hum Mol Genet       Date:  1994-03       Impact factor: 6.150

9.  Tight linkage of pyruvate kinase (PKLR) and glucocerebrosidase (GBA) genes.

Authors:  D Glenn; T Gelbart; E Beutler
Journal:  Hum Genet       Date:  1994-06       Impact factor: 4.132

10.  Linkage disequilibrium analysis in young populations: pseudo-vitamin D-deficiency rickets and the founder effect in French Canadians.

Authors:  M Labuda; D Labuda; M Korab-Laskowska; D E Cole; E Zietkiewicz; J Weissenbach; E Popowska; E Pronicka; A W Root; F H Glorieux
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

View more
  13 in total

1.  Haplotypes in the dystrophin DNA segment point to a mosaic origin of modern human diversity.

Authors:  Ewa Zietkiewicz; Vania Yotova; Dominik Gehl; Tina Wambach; Isabel Arrieta; Mark Batzer; David E C Cole; Peter Hechtman; Feige Kaplan; David Modiano; Jean-Paul Moisan; Roman Michalski; Damian Labuda
Journal:  Am J Hum Genet       Date:  2003-09-25       Impact factor: 11.025

2.  A population-genetic test of founder effects and implications for Ashkenazi Jewish diseases.

Authors:  Montgomery Slatkin
Journal:  Am J Hum Genet       Date:  2004-06-18       Impact factor: 11.025

3.  The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients.

Authors:  Tamar H Taddei; Katherine A Kacena; Mei Yang; Ruhua Yang; Advitya Malhotra; Michael Boxer; Kirk A Aleck; Gadi Rennert; Gregory M Pastores; Pramod K Mistry
Journal:  Am J Hematol       Date:  2009-04       Impact factor: 10.047

Review 4.  The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews.

Authors:  Avner Thaler; Elissa Ash; Ziv Gan-Or; Avi Orr-Urtreger; Nir Giladi
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

5.  Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi Jews.

Authors:  R Durst; R Colombo; S Shpitzen; L B Avi; Y Friedlander; R Wexler; F J Raal; D A Marais; J C Defesche; M Y Mandelshtam; M J Kotze; E Leitersdorf; V Meiner
Journal:  Am J Hum Genet       Date:  2001-04-17       Impact factor: 11.025

6.  The USH2A c.2299delG mutation: dating its common origin in a Southern European population.

Authors:  Elena Aller; Lise Larrieu; Teresa Jaijo; David Baux; Carmen Espinós; Fernando González-Candelas; Carmen Nájera; Francesc Palau; Mireille Claustres; Anne-Françoise Roux; José M Millán
Journal:  Eur J Hum Genet       Date:  2010-02-10       Impact factor: 4.246

7.  LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago.

Authors:  Cyrus P Zabetian; Carolyn M Hutter; Dora Yearout; Alexis N Lopez; Stewart A Factor; Alida Griffith; Berta C Leis; Thomas D Bird; John G Nutt; Donald S Higgins; John W Roberts; Denise M Kay; Karen L Edwards; Ali Samii; Haydeh Payami
Journal:  Am J Hum Genet       Date:  2006-08-17       Impact factor: 11.025

8.  Origin and spread of the 1278insTATC mutation causing Tay-Sachs disease in Ashkenazi Jews: genetic drift as a robust and parsimonious hypothesis.

Authors:  Amos Frisch; Roberto Colombo; Elena Michaelovsky; Mazal Karpati; Boleslaw Goldman; Leah Peleg
Journal:  Hum Genet       Date:  2004-01-15       Impact factor: 4.132

9.  Specific mutations in the HEXA gene among Iraqi Jewish Tay-Sachs disease carriers: dating of founder ancestor.

Authors:  Mazal Karpati; Ephraim Gazit; Boleslaw Goldman; Amos Frisch; Roberto Colombo; Leah Peleg
Journal:  Neurogenetics       Date:  2003-11-27       Impact factor: 2.660

10.  High Rates of Three Common GJB2 Mutations c.516G>C, c.-23+1G>A, c.235delC in Deaf Patients from Southern Siberia Are Due to the Founder Effect.

Authors:  Marina V Zytsar; Marita S Bady-Khoo; Valeriia Yu Danilchenko; Ekaterina A Maslova; Nikolay A Barashkov; Igor V Morozov; Alexander A Bondar; Olga L Posukh
Journal:  Genes (Basel)       Date:  2020-07-21       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.